Botanical species · safety record

Phragmites australis

The EFSA Compendium of Botanicals holds 7 constituent measurements for Phragmites australis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Phragmites australis (Cav.) Trin. ex Steud.

7Constituent measurements

0Safety records

2Cited sources

152Licensed products (Canada)

Also recorded as

Phragmites communis Trin.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 152 licensed products naming Phragmites australis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh

Source material stated

Rhizome

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
4-hydroxybenzaldehyde	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Gallic acid	Leaves	Solvent extraction	441 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Gallic acid	Stem / stalk	Solvent extraction	29 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Gallic acid	Roots and other underground parts	Solvent extraction	41 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Gallic acid	Flower	Solvent extraction	75 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Gallic acid	Roots and other underground parts	Solvent extraction	39 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
P-coumaric acid	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Nikaido, T., Sung, Y.-I., Ohmoto, T., Sankawa, U. Inhibitors of Cyclic Adenosine 3',5'-Monophosphate Phosphodiesterase in Phyllostachys nigra Munro var. henonis Stapf. and Phragmites communis Trin., and Inhibition by Related Compounds. Chemical and pharmaceutical bulletin, 1984, vol. 32, no. 2, p. 578-584. DOI
Uddin, Md N., Robinson, Randall W., Caridi, Domenic. Phytotoxicity induced by Phragmites australis: an assessment of phenotypic and physiological parameters involved in germination process and growth of receptor plant. Journal of plant interactions, 2014, vol. 9, no. 1, p. 338-353. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature